Crucial role of cytokines in sex steroid formation in normal and tumoral tissues

Molecular and Cellular Endocrinology

Volumn 171, Issue 1-2, 2001, Pages 25-40

  Simard, Jacques ^a   Gingras, Sebastien ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

3 Hydroxysteroid dehydrogenase 5 4 isomerase; Breast cancer; Colon cancer; Interleukin 4; Interleukin 6; Keratinocyte; Prostate cancer; Signal transducers and activators of transcription; STAT Binding element, sex steroids

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTENEDIONE; CYTOKINE; ESTROGEN RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; STAT6 PROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE;

BREAST CANCER; CELL CULTURE; CELL IMMORTALIZATION; CELL SPECIFICITY; COLON CANCER; DNA BINDING; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; MALE; PRECURSOR; PRIORITY JOURNAL; PROSTATE EPITHELIUM; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; STEROIDOGENESIS; STROMA CELL; TISSUE; TISSUE GROWTH; TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; UTERINE CERVIX CANCER;

EID: 0035931345     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00387-7     Document Type: Article

References (130)

1. Steroidal regulation of oestradiol-17β-dehydrogenase activity of the human breast cancer cell line MCF-7
2. Effects of human breast fibroblasts on growth and 17β-oestradiol dehydrogenase activity in MCF-7 cells in culture
3. Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17β-oestradiol dehydrogenase activity
4. Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17β-oestradiol levels
5. Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland
6. Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV
7. Steroid hormone receptors in human colon cancers
8. Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4
9. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survival
10. Endogenous hormones and breast cancer risk
11. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells
12. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells
13. Potent stimulatory effect of interleukin-lα on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast cancer cells
14. Growth independent induction of spermidine transport by IL-4 and IL-13 in ZR-75-1 human breast cancer cells
15. The relationship between 17β-HSD activity and oestrogen concentrations in human breast tumours and in normal breast tissue
16. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of post-menopausal patients with metastatic breast carcinoma: results of 2 randomized double-blind controlled multiinstitutional trials
17. Effect of dehydroepiandrosterone and of the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts
18. Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells
19. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
20. STATs and gene regulation
21. The role of estrogens in growth regulation of breast cancer
22. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes
23. Expression and localization of the Th2-type cytokine interleukin-13 and its receptor in the placenta during human pregnancy
24. A wide range of human cancers express interleukin-4 (IL-4) receptors that can be targeted with chimeric toxin composed of IL-4 and Pseudomonas exotoxin
25. Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4
26. Autocrine and paracrine growth factors in the normal and neoplastic breast
27. Expression and function of the cytokine receptor superfamily on breast cancer
28. Biologic activity of dehydroepiandrosterone sulfate in man
29. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase
30. Characterization, expression, and immunohistochernical localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase inhuman skin
31. The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells
32. Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry
33. Hormone replacement therapy and risk of colon and rectal cancer
34. Multiple pathways mediate interleukin-4 induced 3β-hydroxysteroid dehydrogenase/isomerase type 1 gene expression in human breast cancer cells
35. Induction of 3β-hydroxysteroid dehydrogenase/isomerase type 1 gene transcription in human breast cancer cell lines and in normal epithelial cells by interleukin-4 and interleukin-13
36. Induction of 3β-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines
37. Postmenopausal hormone use and risk for colorectal cancer and adenoma
38. Correlation of in vivo and in vitro activities of some naturally occurring androgens using a radioreceptor assay for 5α-dihydrotestosterone with rat prostate cytosol receptor protein
39. The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines
40. A meta-analysis of hormone replacement therapy and colon cancer in women
41. Immunolocalisation of interleukin-4 and interleukin-4 receptor in placenta and fetal membranes in association with pre-term labour and pre-eclampsia
42. An interleukin-4-induced transcription factor: IL-4 Stat
43. STATs: Signal transducers and activators of transcription
44. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
45. Human keratinocytes constitutively express IL4 receptor molecules and respond to IL-4 with an increase in B7/BB1 expression
46. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer
47. Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance
48. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
49. Macrophages in human breast disease: a quantitative immunohistochemical study
50. Interleukin-6 family of cytokines and gp130
51. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-gammainduced nuclear binding factor
52. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4
53. Determination of cDNA, gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7(1)
54. Intracrinology
55. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology
56. History of LHRH agonist and combination therapy in prostate cancer
57. Complete androgen blockade for the treatment of prostate cancer
58. Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues
59. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
60. Androgens and breast cancer
61. Regulation of STAT-dependent pathways by growth factors and cytokines
62. JAKS and STATS: Biological implications
63. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz[a]anthracene (DMBA) in the rat
64. Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3β/17β-HSD activity and cellular distribution
65. Human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids
66. Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4
67. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz[a]anthracene (DMBA)-induced mammary carcinoma in the rat
68. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase
69. Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells
70. Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD), 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey
71. Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues
72. Cytosolic and nuclear androgen receptors in colorectal adenomas
73. The regulation of 3β-hydroxysteroid dehydrogenase expression
74. 3H-estradiol by normal breast and breast tumour tissues in post-menopausal women
75. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling
76. Interleukin-13 receptor α′ but not a chain: A functional component of interleukin-4 receptors
77. Inhibition of 1,2-dimethy1hydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone
78. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells
79. Importance of estrogen sulfates in breast cancer
80. Interleukin-4: a prototypic immunoregulatory lymphokine
81. Expression and regulation of 17β-hydroxysteroid dehydrogenase type
82. 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17βHSD/KSR enzymes
83. Retinoic acids increase 17β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoyphorbol-13 acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells
84. Sebaceous gland response in man to the administration of testosterone, Δ4-androstenedione, and dehydroisoandrosterone
85. Stimulation of cell proliferation and estrogenic response by adrenal C19-Δ5-steroids in the ZR-75-1 human breast cancer cell line
86. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line
87. Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line
88. Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line
89. 17β-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: Regulation of expression by a progestin
90. Increased expression of interleukin-4 receptors on psoriatic epidermal cells
91. Regulation of aromatase and sulphatase in breast tumour cells
92. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-13 but are not required for mitogenesis
93. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissue
94. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis
95. Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene
96. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads
97. The estrogenic and antiestrogenic activities of androgens in female target tissues
98. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma
99. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13
100. Estrogenic effects of 5-androstene-3β,17β-diol at physiological concentrations and its possible implications in the etiology of breast cancer
101. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
102. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency
103. Molecular biology and genetics of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene family
104. Expression of the CYP19 (aromatase) gene:an unusual case of alternative promoter usage
105. The relationship between the vitro activity of 3β-hydroxysteroid dehydrogenase Δ5-Δ4-isomerase in human sebaceous glands and their secretory activity in vivo
106. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland
107. Multiple forms of 17β-hydroxysteroid dehydrogenase in human breast tissue
108. STAT6: its role in interleukin-4-mediated biological functions
109. Decreased adherence of interleukin-6-treated breast carcinoma cells can lead to separation from neighbors after mitosis
110. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells
111. Steroids in normal and neoplastic breast tissues
112. Androgen metabolism in the skin of hirsute women
113. Inhibition of colon and breast carcinoma cell growth by interleukin-4
114. Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism
115. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells
116. Endogenous concentratrions and subcellular distribution of estrogens in normal and malignant human breast cancer tissues
117. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentration in cancerous and normal glandular breast tissue in postmenopausal women
118. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas
119. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines
120. Elevated levels of members of the STAT family of transcrition factors in breast carcinoma nuclear extracts
121. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer
122. The importance of steroid hormones in prostate cancer
123. The JAK/STAT pathway
124. A and B forms of the androgen receptor are expressed in a variety of human tissues
125. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro
126. Interleukin 4-induced proliferation in normal human keratinocytes is associated with c-myc gene expression and inhibited by genistein
127. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter
128. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
129. Interleukin 13 elicits a subset of the activities of its close relative interleukin 4
130. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction